文献速递美容整形乳房整形与再造创面修复

整形外科标本的常规病理评估:我们是否在浪费时间和金钱?

Routine Pathologic Evaluation of Plastic Surgery Specimens: Are We Wasting Time and Money?
PubMed 文献 · Plast Reconstr Surg · 2018-01-01

研究查询了两家医院2015年1月至12月间送检的759份整形外科标本,其中161份仅要求大体检查,所有标本均无临床显著发现,仅1例偶然发现乳腺皮肤脂溢性角化病,2015年总收费430,095美元。作者认为结果不支持对所有整形外科标本进行常规病理检查,仅在有临床怀疑或病史需要时才选择性送检。

要点

  • 759份整形外科标本中无临床显著病理发现,仅1例偶然发现脂溢性角化病。
  • 2015年标本病理检查总收费430,095美元。
  • 作者认为不支持常规病理检查所有整形外科标本,仅在有临床怀疑或病史需要时选择性送检。

核心结论

  • 临床显著病理结果的低频率不支持对所有整形外科标本进行常规病理检查。
  • 作者认为仅在有临床怀疑或病史需要评估时才选择性送检。
  • 通过消除不必要的组织学或宏观检查,可能实现显著的成本节约。

研究设计与样本

  • 回顾性查询两家医院2015年1月至12月间送检的整形外科相关标本,排除非整形手术标本,获取病理诊断和成本数据。

主要发现

  • 共识别759份标本,其中161份送检时明确要求仅做大体检查。
  • 所有标本中无临床显著发现,仅1例偶然发现乳腺皮肤脂溢性角化病。
  • 2015年总收费430,095美元。

临床怎么用

  • 作者认为仅在有临床怀疑或病史需要评估时才选择性送检标本。
  • 作者认为消除不必要的组织学或宏观检查可能实现显著成本节约。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent health care changes have encouraged efforts to decrease costs. In plastic surgery, an area of potential cost savings includes appropriate use of pathologic examination. Specimens are frequently sent because of hospital policy, insurance request, or habit, even when clinically unnecessary. This is an area where evidence-based guidelines are lacking and significant cost-savings can be achieved. METHODS: All specimen submitted for pathologic examination at two hospitals between January and December of 2015 were queried for tissue expanders, breast implants, fat, skin, abdominal pannus, implant capsule, hardware, rib, bone, cartilage, scar, and keloid. Specimens not related to plastic surgery procedures were excluded. Pathologic diagnosis and cost data were obtained. RESULTS: A total of 759 specimens were identified. Of these, 161 were sent with a specific request for gross examination only. There were no clinically significant findings in any of the specimens. There was one incidental finding of a seborrheic keratosis on breast skin. The total amount billed in 2015 was $430,095. CONCLUSIONS: The infrequency of clinically significant pathologic examination results does not support routine pathologic examination of all plastic surgery specimens. Instead, the authors justify select submission only when there is clinical suspicion or medical history that warrants evaluation. By eliminating unnecessary histologic or macroscopic examination, significant cost savings may be achieved.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Fisher M, Alba B, Bhuiya T, et al. Routine Pathologic Evaluation of Plastic Surgery Specimens: Are We Wasting Time and Money? Plast Reconstr Surg. 2018. PMID: 29485577. doi:10.1097/PRS.0000000000004129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。